The Scientist

» FDA and cell & molecular biology

Most Recent

image: Theranos CEO Presents New Device

Theranos CEO Presents New Device

By | August 2, 2016

The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.

0 Comments

image: Wanted: Transcriptional Regulators

Wanted: Transcriptional Regulators

By | August 1, 2016

Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.

0 Comments

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

2 Comments

Mismatched ancestral origins of mitochondrial and nuclear DNA boost mouse health.

1 Comment

image: Immune Cell–Stem Cell Cooperation

Immune Cell–Stem Cell Cooperation

By , , and | July 1, 2016

Understanding interactions between the immune system and stem cells could pave the way for successful stem cell–based regenerative therapies.

1 Comment

image: Immune Cells' Roles in Tissue Maintenance and Repair

Immune Cells' Roles in Tissue Maintenance and Repair

By , , and | July 1, 2016

The cells of the mammalian immune system do more than just fight off pathogens; they are also important players in stem cell function and are thus crucial for maintaining homeostasis and recovering from injury.

0 Comments

image: NYU Halts Studies, Suspends Investigator

NYU Halts Studies, Suspends Investigator

By | June 28, 2016

Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.

2 Comments

image: Exercise-Induced Muscle Factor Promotes Memory

Exercise-Induced Muscle Factor Promotes Memory

By | June 23, 2016

Running releases an enzyme that is associated with memory function in mice and humans.  

3 Comments

image: Creating a DNA Record with CRISPR

Creating a DNA Record with CRISPR

By | June 9, 2016

Researchers repurpose a bacterial immune system to be a molecular recording device.

0 Comments

The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS